Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases
about
Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.Clinico-microbiological profile of urinary tract infection in south IndiaHigh Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in CyprusMultidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India.Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department.In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains.Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.Aetiology and antibiotic resistance issues regarding urological procedures.Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU).Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark.Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and Coresistance phenotype among recent Escherichia coli isolates from U.S. veterans.Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children.Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae.In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.
P2860
Q34140513-8F5B4055-8D3D-4402-8ACF-940FFE93C7DAQ35030163-4346CC77-4685-4C95-95A3-CBB276BF555DQ36456613-1D165230-7541-4772-AA1E-3C4646270F6DQ36792780-B5484297-8F7C-4351-AE14-EB0F127F7600Q37351384-8548E599-4EAE-4020-82E0-47C268DCD8ECQ37389468-7E24540C-FD40-4426-9987-8CD0D9683238Q38208281-904593CF-9258-4402-AD19-DACCF41E5F65Q38253257-0B5C5A01-3AB3-413D-9E21-951930E9FB62Q38739545-5DA0B491-8A73-4FC0-8874-10B28F8549A9Q38833839-02E9840B-EED3-4898-B219-4A56B8A536D1Q38849466-2831F60A-457C-4BA2-9FD1-9E8F24C9045AQ41506040-FEA281C6-148D-4F8D-BFB5-D71232ADEDD5Q42374450-D03469EE-F324-4BBB-BEF5-9975D0B452ADQ42597562-A001BBC0-62D0-4E24-B7C4-4257887A88F8Q42930222-104EEAE6-B40D-44BD-83DA-7DDD061E4A42Q47595207-148A7A3A-6269-48FE-9E8D-11F09BCD93A8Q52643832-BB8D98EB-96EA-4FCE-B701-3667C480E49CQ54389084-B3F670FE-8CAF-4ED1-8541-66657BA0E963
P2860
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral and parenteral therapeuti ...... ended-spectrum beta-lactamases
@en
Oral and parenteral therapeuti ...... nded-spectrum beta-lactamases.
@nl
type
label
Oral and parenteral therapeuti ...... ended-spectrum beta-lactamases
@en
Oral and parenteral therapeuti ...... nded-spectrum beta-lactamases.
@nl
prefLabel
Oral and parenteral therapeuti ...... ended-spectrum beta-lactamases
@en
Oral and parenteral therapeuti ...... nded-spectrum beta-lactamases.
@nl
P2093
P2860
P356
P1476
Oral and parenteral therapeuti ...... ended-spectrum beta-lactamases
@en
P2093
James H Jorgensen
James S Lewis
Monica L Herrera
Vidhya Prakash
P2860
P304
P356
10.1128/AAC.01519-08
P407
P577
2009-01-05T00:00:00Z